Clinical efficacy and safety of transcatheter aortic valve replacement for patients with severe pure native aortic regurgitation
Authors:
- Jiantao ChenJCJiantao Chen
- Yi ZhangYZYi Zhang
- Kangni FengKFKangni Feng
- Suiqing HuangSHSuiqing Huang
- Hanri XiaoHXHanri Xiao
- Mengya LiangMLMengya Liang
- Zhongkai WuZWZhongkai Wu
Open Access
- 1 July 2025
- journal article
- Published by China Science Publishing & Media Ltd. in Journal of Zhejiang University (Medical Sciences)
- Vol. 54 (4) , 529-540
Abstract
Objective To evaluate the early clinical efficacy and safety of trans-catheter aortic valve replacement (TAVR) for patients with severe pure native aortic regurgitation (PNAR). Methods A retrospective analysis was conducted on 48 PNAR patients who underwent TAVR at the Department of Cardiac Surgery, the First Affiliated Hospital of Sun Yat-sen University between March 2019 and February 2025, including 25 cases with transfemoral approach (TF-TAVR group) and 23 cases with transapical approach (TA-TAVR group). Efficacy and safety were assessed by analyzing baseline characteristics, all-cause mortality, and procedure-related complications. Results Compared with the TA-TAVR group, the TF-TAVR group exhibited significantly smaller aortic annulus circumference and diameter, left ventricular outflow tract circumference and diameter, diameters of the left, right, and non-coronary sinuses, and sinotubular junction (STJ) diameter, with a shorter distance from the STJ to the aortic valve basal ring plane (all P0.05). No conduction block events occurred in TA-TAVR group, while high-grade atrioventricular block, left bundle branch block, permanent pacemaker implantation occurred in TF-TAVR group during hospitalization or 1-year follow-up (12.00%, 4.00%, and 12.00%, respectively). Conclusions TAVR demonstrates high success rates and acceptable safety for severe PNAR patients who are unable to undergo traditional surgical procedures. Although TF-TAVR may face more challenges in certain complex cases than TA-TAVR, the overall outcomes are promising.Keywords
This publication has 31 references indexed in Scilit:
- Native aortic valve regurgitation: TAVR’s place in the PANTHEONIndian Journal of Thoracic and Cardiovascular Surgery, 2023
- Transcatheter Aortic Valve Implantation With J-Valve: 2-Year Outcomes From a Multicenter StudyThe Annals of Thoracic Surgery, 2021
- Long-Term Outcomes in Patients With New-Onset Persistent Left Bundle Branch Block Following TAVRJACC: Cardiovascular Interventions, 2019
- Computed Tomography Imaging in the Context of Transcatheter Aortic Valve Implantation (TAVI)/Transcatheter Aortic Valve Replacement (TAVR)JACC: Cardiovascular Imaging, 2019
- Direct Comparison of Feasibility and Safety of Transfemoral Versus Transaortic Versus Transapical Transcatheter Aortic Valve ReplacementJACC: Cardiovascular Interventions, 2016
- Predictors of Permanent Pacemaker Implantation in Patients With Severe Aortic Stenosis Undergoing TAVRJACC, 2014
- Bleeding Complications After Surgical Aortic Valve Replacement Compared With Transcatheter Aortic Valve ReplacementJACC, 2014
- Burden of valvular heart diseases: a population-based studyThe Lancet, 2006
- A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart DiseaseEuropean Heart Journal, 2003
- Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)The American Journal of Cardiology, 1999